Effect of Simeox® on Residual Volume in COPD Patients With Pulmonary Hyperinflation

NCT07665931 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

23

Enrollment

OTHER

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease (COPD)
Pulmonary Hyperinflation

Interventions

DEVICE: Simeox

Sponsor

Azienda Socio Sanitaria Territoriale di Lodi